Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. to 1:30 p.m.

Pharmacy 98

Pharmacy Government Drugs Pharmaceuticals 98

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

OCTOBER 5, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. In the video excerpt below, I describe these new approaches that plans offset specialty drug expenses. Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 97

Pharmaceuticals Marketing Drugs 97

Drug Channels

SEPTEMBER 12, 2023

On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. As always, we have updated all market and industry data with the most current information available. d/b/a Drug Channels Institute.

Pharmaceuticals 52

Pharmaceuticals Pharmacy Biosimilars Licensing 52

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. reviews AmerisourceBergen’s entry into the European distribution market. (We Section 4.4. Section 7.4.4. Section 6.1.5.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Pharmaceuticals 96

Drug Discovery World

FEBRUARY 12, 2024

Dr Pandora Pound , Fellow Oxford Centre for Animal Ethics explores the hinderances of animal testing in pharma and why new technologies such AI, genomics and synthetic biology c an further drug development. In this sort of research, scientists try to reproduce the disease in animals and then test new drugs on these animals.

Animal Testing 148

Animal Testing Disease Trials Research 148

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. d/b/a Drug Channels Institute. to 1:30 p.m.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs Pharmacy 98

The Premier Consulting Blog

JULY 9, 2023

During the development of new small molecule drug products, developers must conduct impurity and degradant evaluation at several points in the program and to varying degrees. These evaluations include the active pharmaceutical ingredient (API), also known as the drug substance, and the drug product (formulated product).

Small Molecule 52

Small Molecule DNA Drugs Clinical Development 52

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 75

Pharmacy Biosimilars Production Marketing 75

Drug Channels

MARCH 15, 2022

Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including the Table of Contents and a List of Exhibits) New Drug Channels Institute Study Examines Impact of COVID-19 on U.S.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Pharmacy 52

The Pharma Data

AUGUST 19, 2020

Multiple Attorney Generals from across the US are seeking billions of dollars in damages to settle opioid cases against major pharmaceutical manufacturers and distributors. . New York State also says Teva made 20% of all opioids distributed from 2006 to 2014 in the region and marketed its products for off-label uses.

Pharmaceuticals 52

Pharmaceuticals Doctors International FDA 52

Drug Channels

DECEMBER 1, 2020

During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. Pharmacy and healthcare provider markets experienced unprecedented volatility. distribution channels for prescription drugs. Pharmaceutical wholesalers have maintained shipments and operational capacity. to 1:15 p.m.

Pharmacy 52

Pharmacy Vaccine Drugs Pharmaceuticals 52

Drug Channels

JULY 11, 2022

Drug Channels readers will save 10% off the current registration rate when they use code 22DC10 *. Director, Cell Therapy Operations and Patient Services, Gamida Cell Austin Fisher, Executive Director, CART Patient Support and Distribution, Autolus Chris Boneham, Vice President Market Access U.S., d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Compliance 98

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — CNS PHARMACEUTICALS AG , Inc. manufacturer, Pharmaceutics International, Inc. (“Pii”), has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Treatment 52

Drug Channels

SEPTEMBER 18, 2023

Drug Channels subscribers: Save 10% off the current registration rate with promo code 21DC10*. Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Copyright © 2006-2023 Pembroke Consulting, Inc. Register today.

Compliance 75

Compliance Pharmaceuticals Disease Drugs 75

Drug Channels

MAY 9, 2022

Drug Channels readers will save 10% off the current registration rate when they use code 22DC10*. Attorney’s Office, District of New Jersey Lauren Powell, MPA, PhD, Vice President, US Health Equity & Community Wellness, Takeda Pharmaceuticals PLUS! Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Pharmaceuticals Government 75

Drug Channels

MARCH 19, 2023

Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. NEW THIS YEAR!

Science 75

Science Government Pharmaceuticals Production 75

Drug Target Review

JUNE 19, 2024

Also, many companies never reached the point where they received validation from big pharmaceutical companies. From 2002 until 2004, Mr Culley was Director of Business Development and Marketing for Immusol, Inc. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc. from May 2017 until December 2022.

Therapies 83

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 83

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. That’s about six times faster than the overall mail and specialty market. That’s about six times faster than the overall mail and specialty market.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 52

Drug Channels

OCTOBER 30, 2023

Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmaceutical Companies 74

Pharmaceutical Companies Regulations Pharmaceuticals Drugs 74

Drug Channels

SEPTEMBER 21, 2020

Drug Channels readers will save $300 off the standard registration rate when they use code MDU494.*. Drug Channels readers will save $300 off the standard registration rate when they use code MDU494.*. Drug Channels, or any of its employees. Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

JUNE 1, 2020

Virtual business sessions cover such topics as market trends, the specialty pipeline, accreditation, federal health policy, digital health, and more. Two highlights: The State of Specialty Pharmacy 2020: Market Data and Trends —Adam J. Fein, Drug Channels Institute (That’s me!) Copyright © 2006-2020 Pembroke Consulting, Inc.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharmaceuticals Marketing 40

Drug Channels

NOVEMBER 23, 2020

Excusive Offer for Drug Channels Readers Register Now To SAVE $300 * using promo code CHR300. Drug Channels, or any of its employees. Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmaceuticals 40

Pharmaceuticals Marketing Drugs 40

Drug Channels

MARCH 14, 2022

Fein of Drug Channels Institute. The Summit will again welcome the full spectrum of organizations working in the pharmacy, life sciences & patient services market. Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

Drug Channels

AUGUST 11, 2020

Time for our annual update on pricing at five of the largest pharmaceutical manufacturers—Eli Lilly, Janssen, Merck, Novartis, and Sanofi. When rebates and discounts were factored in, drug prices declined—or grew slowly—in 2019. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Government 52

Government Pharmaceuticals Drugs Marketing 52

Drug Channels

NOVEMBER 8, 2020

Drug Channels readers will save $200 off the standard rate when they use code KTP933 and register prior to November 20th.*. Drug Channels readers will save $200 off the standard rate when they use code KTP933 and register prior to November 20th.*. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

Drug Channels

MAY 3, 2021

Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 21CCCDC10 , so download the complete conference agenda and reserve your seat today! Drug Channels, or any of its employees. Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 40

Pharmacy Government Pharmaceuticals Science 40

The Pharma Data

APRIL 4, 2023

With eight marketed biosimilars Sandoz is offering the broadest biosimilar portfolio and is the leading biosimilars company in Europe with more than two decades of experience. Recently, US Food and Drug Administration (FDA) also approved the citrate-free HCF of Hyrimoz ® (adalimumab-adaz) injection.

Biosimilars 40

Biosimilars Pharmacokinetics FDA Approval Packaging 40

Drug Channels

OCTOBER 26, 2020

Drug Channels readers will save $300 off the standard rate when they use code GNB425 and register prior to October 30th.*. Drug Channels readers will save $300 off the standard rate when they use code GNB425 and register prior to October 30th.*. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Government 40

Government Pharmaceuticals Science Production 40

Drug Channels

OCTOBER 19, 2020

Drug Channels readers will save $300 off the standard rate when they use code GJE973 and register prior to October 30th.*. Drug Channels readers will save $300 off the standard rate when they use code GJE973 and register prior to October 30th.*. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

Agency IQ

NOVEMBER 10, 2023

Services incurring fees include marketing authorization applications, variations, scientific advice, and inspections. Fees supplemental to the basic fees can be collected for authorization of additional strengths and pharmaceutical forms. literature monitoring), since national regulators charge their own fees.

Regulations 40

Regulations Pharmaceuticals Government Therapies 40

The Pharma Data

SEPTEMBER 17, 2020

Basel, 18 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Food and Drug Administration (FDA). Roche is the majority shareholder in Chugai Pharmaceutical, Japan. In 2019, Roche invested CHF 11.7 Academic Press.

Vaccine 52

Vaccine Virus Clinical Trials Immune Response 52

Agency IQ

APRIL 19, 2024

Draft guideline modernizes EMA recommendations on quality of inhaled, nasal products The EMA has published a draft revision to its 2006 guideline on product development quality considerations for inhaled and nasal products. In 2006, the EMA published a guideline for developers regarding the pharmaceutical quality of these products.

Production 40

Production Pharmaceuticals Regulations Drugs 40